Search

Author/Creator Learoyd, Maria

1. Efficacy and Safety Exposure‐Response Analyses of Olaparib Capsule and Tablet Formulations in Oncology Patients. Issue 6 (22nd February 2019)

Authors:
Zhou, Diansong; Li, Jianguo; Learoyd, Maria; Bui, Khanh; Berges, Alienor; Milenkova, Tsveta; Al‐Huniti, Nidal; Tomkinson, Helen; Xu, Hongmei
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 105:Issue 6(2019)
Page Start:
1492
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial. Issue 7 (July 2018)

Authors:
Clarke, Noel; Wiechno, Pawel; Alekseev, Boris; Sala, Nuria; Jones, Robert; Kocak, Ivo; Chiuri, Vincenzo Emanuele; Jassem, Jacek; Fléchon, Aude; Redfern, Charles; Goessl, Carsten; Burgents, Joseph; Kozarski, Robert; Hodgson, Darren; Learoyd, Maria; Saad, Fred
Journal:
Lancet oncology
Issue:
Volume 19:Issue 7(2018)
Page Start:
975
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairment. Issue 9 (5th April 2020)

Authors:
Rolfo, Christian; Isambert, Nicolas; Italiano, Antoine; Molife, L. Rhoda; Schellens, Jan H.M.; Blay, Jean‐Yves; Decaens, Thomas; Kristeleit, Rebecca; Rosmorduc, Olivier; Demlova, Regina; Lee, Myung‐Ah; Ravaud, Alain; Kopeckova, Katerina; Learoyd, Maria; Bannister, Wendy; Locker, Gershon; de Vos‐G...
Journal:
British journal of clinical pharmacology
Issue:
Volume 86:Issue 9(2020)
Page Start:
1807
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗